These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 18484430
1. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin. Kavala M, Kocaturk E, Zindanci I, Turkoglu Z, Altintas S. J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430 [Abstract] [Full Text] [Related]
2. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy. Anavekar NS, Kelly R. Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202 [Abstract] [Full Text] [Related]
3. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Browning CE, Callen JP. Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390 [Abstract] [Full Text] [Related]
4. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin. Davis MD, Wysokinski WE. J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355 [Abstract] [Full Text] [Related]
5. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator. Deng A, Gocke CD, Hess J, Heyman M, Paltiel M, Gaspari A. Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837 [Abstract] [Full Text] [Related]
7. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin. Osada S, Kimura Y, Kawana S. J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830 [Abstract] [Full Text] [Related]
8. [Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome]. Lewerenz V, Burchardt T, Büchau A, Ruzicka T, Megahed M. Hautarzt; 2004 Apr; 55(4):379-81. PubMed ID: 15021932 [Abstract] [Full Text] [Related]
9. Livedoid vasculopathy in a patient with factor V mutation (Leiden). Biedermann T, Flaig MJ, Sander CA. J Cutan Pathol; 2000 Sep; 27(8):410-2. PubMed ID: 10955688 [Abstract] [Full Text] [Related]
13. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin]. Becker A, Stoffels-Weindorf M, Schimming T, Dissemond J. Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447 [Abstract] [Full Text] [Related]
14. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome. Cardoso R, Gonçalo M, Tellechea O, Maia R, Borges C, Silva JA, Figueiredo A. Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092 [Abstract] [Full Text] [Related]
15. [Vasculitis and vasculopathy]. Marković A. Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816 [Abstract] [Full Text] [Related]
16. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Hairston BR, Davis MD, Pittelkow MR, Ahmed I. Arch Dermatol; 2006 Nov; 142(11):1413-8. PubMed ID: 17116831 [Abstract] [Full Text] [Related]
17. A case of livedoid vasculopathy in a 22-year-old man. Leonard A, Pomeranz MK, Franks AG. J Drugs Dermatol; 2004 Nov; 3(6):678-9. PubMed ID: 15624752 [Abstract] [Full Text] [Related]
18. Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin. Clivati Brandt HR, de Lorenzo Messina MC, Belda Júnior W, Costa Martins JE, Criado PR. Int J Dermatol; 2007 Dec; 46(12):1319-20. PubMed ID: 18173539 [No Abstract] [Full Text] [Related]